Ana Viu

Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild‐moderate fibrosis: Results from a real‐world cohort

P. Cordero, J. Calleja, M. Diago, 2018, Liver international : official journal of the International Association for the Study of the Liver.

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

H. D. de Koning, F. Lammert, T. Karlsen, 2022, BMC Public Health.

Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients

M. García-Retortillo, J. Carrión, X. Bessa, 2020, World journal of hepatology.

Follow‐up evaluation of patients with liver test abnormalities detected during SARS‐CoV2 infection

M. García-Retortillo, J. Carrión, X. Bessa, 2022, Journal of viral hepatitis.

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

H. D. de Koning, T. Karlsen, G. Pera, 2022, BMC Public Health.

Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

V. Wong, T. Karlsen, G. Pera, 2023, The Lancet.